This was the stock's third consecutive day of gains.

TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

Animal health company Zoetis (NYSE:ZTS) in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

PARSIPPANY, N.J., February 20, 2025--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences.

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...

Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due ...

Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...